Art

J-GLOBAL ID：200902237478875276   Reference number：06A0576021

Current Evidence of Irinotecan Combination Chemotherapy with TS-1 in Patients with Advanced Colorectal Cancer

大腸癌化学療法-最近の併用投与-TS-1/Irinotecan併用療法-現在の知見-

Author (1)： GOTO AYUMU (国立がんセ 中央病院 消化器内科)
Material： 癌と化学療法  (Japanese Journal of Cancer and Chemotherapy)
Volume： 33  Issue： 7  Page： 896-900  Publication year： Jul. 15, 2006 
JST Material Number： Z0938A  ISSN： 0385-0684  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *combined effect ,...
Semi thesaurus term： FOLFIRI療法 ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=06A0576021&from=J-GLOBAL&jstjournalNo=Z0938A") }}

JST classification (3)： Tumors(=neoplasms)of digestive system  (GH04000D) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (5)： Fluorouracil ,  CPT-11 ,  TS-1 ,  Irinotecan ,  Leucovorin

Reference (16)：

• Tournigand C, Andre T, Achille E, et al: FOLFIRI followed by FOLFOX 6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol 22: 229-237, 2004.
• Meta-analysis Group in Cancer: Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 16: 301-308, 1998.
• Ohtsu A, Baba N, Sakata Y, et al: Phase II study of S-1, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal carcinoma. Br J Cancer 83: 141-145, 2000.
• Shirao K, Ohtsu A, Takada H, et al: Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma. Cancer 100: 2355-2361, 2004.
• Yamada Y, Yasui H, Goto A, et al: Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer. Int J Clin Oncol 8: 374-380, 2003.

Terms in the title (4)： 大腸癌化学療法 ,  併用投与 ,  TS-1 ,  併用療法